GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Leadman Biochemistry Co Ltd (SZSE:300289) » Definitions » Cyclically Adjusted Revenue per Share

Beijing Leadman Biochemistry Co (SZSE:300289) Cyclically Adjusted Revenue per Share : ¥1.42 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Beijing Leadman Biochemistry Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Beijing Leadman Biochemistry Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥0.175. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥1.42 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Beijing Leadman Biochemistry Co's average Cyclically Adjusted Revenue Growth Rate was -1.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 1.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Beijing Leadman Biochemistry Co was 1.40% per year. The lowest was 1.40% per year. And the median was 1.40% per year.

As of today (2024-05-28), Beijing Leadman Biochemistry Co's current stock price is ¥4.53. Beijing Leadman Biochemistry Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥1.42. Beijing Leadman Biochemistry Co's Cyclically Adjusted PS Ratio of today is 3.19.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Beijing Leadman Biochemistry Co was 6.71. The lowest was 2.77. And the median was 4.39.


Beijing Leadman Biochemistry Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Beijing Leadman Biochemistry Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Leadman Biochemistry Co Cyclically Adjusted Revenue per Share Chart

Beijing Leadman Biochemistry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.36 1.39 1.44 1.42

Beijing Leadman Biochemistry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.44 1.42 1.42 1.42 1.42

Competitive Comparison of Beijing Leadman Biochemistry Co's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Beijing Leadman Biochemistry Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Leadman Biochemistry Co's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beijing Leadman Biochemistry Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Beijing Leadman Biochemistry Co's Cyclically Adjusted PS Ratio falls into.



Beijing Leadman Biochemistry Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Beijing Leadman Biochemistry Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.175/115.2271*115.2271
=0.175

Current CPI (Mar. 2024) = 115.2271.

Beijing Leadman Biochemistry Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.316 98.200 0.371
201409 0.278 98.900 0.324
201412 0.575 99.000 0.669
201503 0.395 99.900 0.456
201506 0.402 99.500 0.466
201509 0.345 100.500 0.396
201512 0.547 100.600 0.627
201603 0.278 102.200 0.313
201606 0.303 101.400 0.344
201609 0.321 102.400 0.361
201612 0.429 102.600 0.482
201703 0.273 103.200 0.305
201706 0.334 103.100 0.373
201709 0.316 104.100 0.350
201712 0.411 104.500 0.453
201803 0.374 105.300 0.409
201806 0.447 104.900 0.491
201809 0.430 106.600 0.465
201812 0.311 106.500 0.336
201903 0.275 107.700 0.294
201906 0.329 107.700 0.352
201909 0.263 109.800 0.276
201912 0.486 111.200 0.504
202003 0.134 112.300 0.137
202006 0.290 110.400 0.303
202009 0.356 111.700 0.367
202012 0.326 111.500 0.337
202103 0.277 112.662 0.283
202106 0.311 111.769 0.321
202109 0.366 112.215 0.376
202112 0.301 113.108 0.307
202203 0.348 114.335 0.351
202206 0.340 114.558 0.342
202209 0.309 115.339 0.309
202212 0.265 115.116 0.265
202303 0.199 115.116 0.199
202306 0.218 114.558 0.219
202309 0.208 115.339 0.208
202312 0.294 114.781 0.295
202403 0.175 115.227 0.175

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Beijing Leadman Biochemistry Co  (SZSE:300289) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Beijing Leadman Biochemistry Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4.53/1.42
=3.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Beijing Leadman Biochemistry Co was 6.71. The lowest was 2.77. And the median was 4.39.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Beijing Leadman Biochemistry Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Beijing Leadman Biochemistry Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Leadman Biochemistry Co (SZSE:300289) Business Description

Traded in Other Exchanges
N/A
Address
No.5 Hongda South Road, Beijing, CHN
Beijing Leadman Biochemistry Co Ltd is a biotechnology company based in China. The company is focusing on research and development, manufacture, and sales of in vitro diagnostic (IVD) products. The company has core competencies in biochemistry, in vitro diagnostic reagents and instruments. Its product offering includes biochemical raw materials such as enzymes, coenzymes, antibodies, buffers, and enzyme substrates; biochemistry diagnostic and companion reagents; and medical test instruments.
Executives
Ding Yao Liang Executives
Wang Xiao Hong Supervisors
Zhang Hai Tao Executives
Zhang Ya Li Supervisors
Sun Qian Director
Wang Jian Hua Directors, executives
Wang Yi Xing Directors, executives
Yang Lu Ping Securities Affairs Representative
Niu Ju Hui Secretary Dong
Zhang Kun Director
Shen Guang Qian Directors, executives
Ma Yan Wen Director
Wang Lan Zhen Directors, executives

Beijing Leadman Biochemistry Co (SZSE:300289) Headlines

No Headlines